Published in Gene Therapy Weekly, October 18th, 1999
Malignant mesothelioma (MM) is an aggressive tumor of the mesothelial lining of the pleura - the delicate membrane covering the lungs and the inner surface of the chest. The cancer is associated with prior exposure to asbestos and is latent for 15 to 40 years. The average survival time for victims following diagnosis is nine months. To date, neither surgery,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.